The controversy on whether PepsiCo and other companies like Kraft and Nestle can continue to contract with a company that uses the cells from a aborted fetus for research has been answered by the federal Securities and Exchange Commission, and the answer is yes.
In a news release today from Children of God for Life, the agency, which has spearheaded the boycott, reports on the decision made last week after an SEC resolution from PepsiCo shareholders asked that they adopt a policy of human rights and stop contracting with a company doing fetal cell research for flavor testing. COG reports:
In a shocking decision delivered Feb 28th, President Obama’s Security and Exchange Commission ruled that PepsiCo’s use of aborted fetal remains in their research and development agreement with Senomyx to produce flavor enhancers falls under “ordinary business operations.”
So it’s ordinary to use an aborted fetus to derive cells on which to run testing for flavor additives? Actually, sadly, it is. Why shouldn’t it be? US legal code actually allows fetal research. Click here for the law. Last year the shareholders of the company filed a resolution with the Securities and Exchange Commission, a federal office that regulates stock, trading, and such practices. The shareholders asked that PepsiCo to stop using this research and adopt a “human rights policy” on the matter. That in itself was a big deal because a shareholder resolution is essentially a public complaint by investors; they don’t air interior dirty laundry unless it’s serious. But in the last week, PepsiCo and the SEC both said, too bad.